Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVS Health

CVS buying Chicago’s Oak Street Health in deal valued at $10.6 billion

CHICAGO — CVS Health plans to buy Chicago-based Oak Street Health in a $10.6 billion deal that aims to expand CVS’s reach into primary care.

Chicago Tribune

3 Winning Stocks to Buy No Matter What the Market Does

Continuing improvements in economic indicators reflect that the U.S. economy is resilient amid the weak earnings forecasts. However, since the market is expected to remain under pressure for some time, it could be wise to add winning stocks, Oracle Corp. (ORCL), CVS Health (CVS), and Halliburton (HAL), to your portfolio.…

StockNews.com

CVS buys Chicago-based Oak Street Health for $10.6B

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

CVS acquires Oak Street primary care for $10.6 billion

CVS Health is plunging deeper into providing primary care with an approximately $10.6 billion deal to acquire Oak Street Health

The Independent UK

Owning These 3 Stocks Could Make You Rich in 10 Years

Consistently falling prices and stronger-than-expected fourth-quarter GDP are renewing hopes about the economy’s overall health. Therefore, it could be wise to add quality stocks with solid fundamentals, Walmart (WMT), Bristol-Myers Squibb (BMY), and CVS Health (CVS), to your portfolio to garner substantial returns in 10 years. Read more….

StockNews.com

5 Unstoppable Stocks You Shouldn't Wait Any Longer to Buy

The Fed’s intention to keep raising interest rates despite the cooling down of inflation could eventually lead to the economy witnessing a recession. Moreover, the World Bank lowered its 2023 global growth forecast by almost half, citing deteriorating economic conditions. Hence, it could be wise to invest in fundamentally sound…

StockNews.com

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

StockNews.com

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

How the best leaders are preparing to navigate a recession—and come out ahead

Current and former corporate leaders share their battle-tested playbooks with Fortune.

Fortune

3 Hot Stocks With More Room to Run in 2023

As inflation shows signs of easing and the Fed is expected to slow the pace of rate hikes, the market’s prospects look bright. Therefore, fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Box (BOX) could keep soaring. Wall Street analysts expect upsides in these stocks over the next 12…

StockNews.com

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

StockNews.com

Walmart offers to pay $3.1 billion to settle opioid lawsuits

The retail giant becomes the latest major player in the drug industry to announce a plan to settle lawsuits filed by state and local governments over the toll of opioids sold at its pharmacies.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

France 24

US pharmacies announce opioid settlements totaling $10 billion

The two largest US pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle on Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart, a third pharmacy behemoth, is in discussions for a deal.

Benzinga

CVS Health Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

WEKU

CVS and Walgreens announce opioid settlements totaling $10 billion

It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

The Independent UK

CVS Health agrees to $5B settlement of opioid lawsuits

CVS Health says it has agreed to pay about $5 billion to state, local and Native American tribal governments to settle lawsuits over the toll of opioids

Benzinga

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bullish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Independent UK

CVS to reduce prices of menstrual products and cover the sales tax: ‘Women deserve quality’

‘We’ve reduced the price on CVS Health brand period products by 25 per cent in core CVS Pharmacy locations,’ the pharmacy said in a satement

Benzinga

This Is What Whales Are Betting On CVS Health

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 10 strange trades.

Benzinga

CVS Health Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 11 strange trades.

StockNews.com

Want to Lower Your Risk? Give These 3 Safe Stocks a Try

The uncertainty surrounding the market and the economy because the Federal Reserve signaled to continue hiking interest rates is making investors seek low-risk investments. Given lower volatility and attractive dividend payments, Johnson & Johnson (JNJ), CVS Health (CVS), and Summit Financial Group (SMMF) could be good candidates to consider on…

1 … 5 6 7 8

People

Elon Musk

29,021 stories

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.